Spero Therapeutics, Inc. SPRO
NASDAQ · United States · Health Technology
$1.19-0.07 (-5.56%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-12 | -0.16 | -0.17 | +5.9% | $0 | — | +0.8%$1.23→$1.24 |
| Q1 2026 | 2026-05-13 | -0.13 | — | — | — | — | +8.7%$2.54→$2.76 |
| Q4 2025 | 2026-03-26 | 0.53 | — | — | — | — | -3.3%$2.41→$2.33 |
| Q3 2025 | 2025-11-13 | -0.13 | -0.25 | +48.0% | — | — | -9.4%$2.66→$2.41 |
| Q2 2025 | 2025-08-12 | -0.03 | -0.38 | +92.1% | — | — | — |
| Q4 2024 | 2025-03-27 | -0.37 | -0.31 | -19.4% | — | — | — |
| Q2 2024 | 2024-08-05 | -0.33 | -0.38 | +13.2% | — | — | — |
| Q1 2024 | 2024-05-15 | -0.24 | -0.06 | -300.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.